Search by Drug Name or NDC
NDC 57237-0064-01 Flecainide Acetate 100 mg/1 Details
Flecainide Acetate 100 mg/1
Flecainide Acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is FLECAINIDE ACETATE.
MedlinePlus Drug Summary
Flecainide is used to prevent certain types of life-threatening irregular heartbeats. Flecainide is in a class of medications called antiarrhythmics. It works by slowing electrical signals in the heart to stabilize the heart rhythm.
Related Packages: 57237-0064-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Flecainide
Product Information
| NDC | 57237-0064 |
|---|---|
| Product ID | 57237-064_c6b596c3-30c8-4bf6-89f6-03026358a3c6 |
| Associated GPIs | 35300010100305 |
| GCN Sequence Number | 000263 |
| GCN Sequence Number Description | flecainide acetate TABLET 100 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 01580 |
| HICL Sequence Number | 000082 |
| HICL Sequence Number Description | FLECAINIDE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Flecainide Acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Flecainide Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | FLECAINIDE ACETATE |
| Labeler Name | Rising Pharma Holdings, Inc. |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202821 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 57237-0064-01 (57237006401)
| NDC Package Code | 57237-064-01 |
|---|---|
| Billing NDC | 57237006401 |
| Package | 100 TABLET in 1 BOTTLE (57237-064-01) |
| Marketing Start Date | 2015-07-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.17953 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | FLECAINIDE ACETATE 100 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis